TCR V α 24 J α 18 Antibodies

Santa Cruz Biotechnology delivers a wide array of TCR Vα 24 Jα 18 monoclonal antibodies to support research in T cell receptor biology. TCR V α 24 J α 18 Antibodies are available for various applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). TCR Vα 24 Jα 18 is crucial for the recognition of lipid antigens presented by CD1d molecules, playing a significant role in the activation of invariant natural killer T (iNKT) cells. Invariant natural killer T cells are essential for bridging innate and adaptive immunity, influencing immune responses against infections and tumors. Understanding the function of TCR Vα 24 Jα 18 is vital for advancing therapeutic strategies in immunology and cancer research. Researchers worldwide rely on TCR Vα 24 Jα 18 monoclonal antibodies to investigate cellular mechanisms and pathways involved in immune system regulation. Exploring TCR Vα 24 Jα 18 functions helps reveal new insights into autoimmune disorders, cancer immunotherapy, and inflammatory conditions. Santa Cruz Biotechnology monoclonal antibodies for TCR Vα 24 Jα 18 research enable scientists to advance our understanding of immune system dynamics and develop innovative therapeutic approaches.